HETEROCYCLIC-ANALOGS OF DNA MINOR-GROOVE ALKYLATING-AGENTS

Citation
Pg. Baraldi et al., HETEROCYCLIC-ANALOGS OF DNA MINOR-GROOVE ALKYLATING-AGENTS, Current pharmaceutical design, 4(3), 1998, pp. 249-276
Citations number
172
Categorie Soggetti
Pharmacology & Pharmacy",Biology
ISSN journal
13816128
Volume
4
Issue
3
Year of publication
1998
Pages
249 - 276
Database
ISI
SICI code
1381-6128(1998)4:3<249:HODMA>2.0.ZU;2-G
Abstract
It is generally accepted that neoplastic transformation is related to genes alteration or oncogene activation. In particular,DNA minor groov e binding drugs have been extensively studied through the years in ord er to influence the regulation of gene expression by means of specific interactions with DNA bases moieties. Pyrrolo[2,1-c].[l,il].benzodiaz epine (PBDs), CC-1065 and distamycins are three classes of minor groov e binders which showed interesting cytotoxicity profiles, refined thro ugh already reviewed processes of SAR studies. Among the modifications to the three families of antitumor compounds, hererocyclic substituti ons have been extensively applied by many groups in order to either mo dify the reactivity profile or introduce extra interactions within the minor groove, thus changing the binding site or modulating the bindin g sequence. The updated material related to these modifications has be en rationalised and ordered in order to offer an overview of the argum ent.